Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Portrayal of Hospital Alcohol Detoxification in France (Alcostop)

18 oktober 2021 bijgewerkt door: University Hospital, Montpellier

Portrayal of Hospital Alcohol Detoxifications and Factors Associated With Longer or Ulterior Hospitalizations in France From 2011 to 2020

Even if hospital alcohol detoxifications are frequent in France, their caracteristicscharacteristics remain unknown. The investigators aim to describe the clinical and paraclinical caracteristicscharacteristics of their patients, their length and geographical repartition, etc… The investigators also aim to evaluate factors associated with longer stays or ulterior re-hospitalization for the same reason. Finally, The investigators aim to compare the stays by facility type.

Studie Overzicht

Gedetailleerde beschrijving

Context:

In France, the consequences of excessive alcohol use are one of the primary reasons for hospitalization. When stopping the substance, patients with an alcohol use disorder can suffer from a potentially fatal alcohol withdrawal syndrome. To mitigate these risks, a withdrawal under medical supervision is possible, either in an outpatient setting or in hospital, where the detoxification can be programmed or imposed. In the course of an alcohol dependent patient's life, re-drinking is not exceptional and the patient may undergo several withdrawals during his or her life.

Psychiatric pathologies, especially anxiety and depression, are more frequent in these patients than in the rest of the population, just as can be somatic pathologies.e. Withdrawal accidents, represented by comital seizures and delirium tremens, can be critical.

In hospital detoxifications, studies do not show any benefit in continuing the stay beyond 10 days, except in the case of somatic or psychiatric complication. However, little information is available on the average length of stay for hospital alcohol detoxification.

Although alcohol dependence issues are very frequent and the resulting withdrawals are relatively common and associated with numerous comorbidities, little data exists at a national level in France.

The aim of this study is to describe these hospital detoxifications: course, duration, frequency and clinical and paraclinical characteristics of the patients. We also wish to analyze which characteristics are associated with longer stays or re-hospitalization and to compare the care according to the facility type.

Objectives:

Main:

- To describe the clinical, paraclinical, and stay characteristics of hospital alcohol detoxification in France

Secondary:

  • To describe the regional distribution of hospital alcohol detoxification
  • To evaluate whether certain clinical characteristics are associated with a longer hospital stays
  • To evaluate whether certain clinical characteristics are associated with subsequent re-hospitalization for the same reason
  • To compare the characteristics of patient stays by type of facility

Methods:

In this descriptive observational study using pre-existing data accessed via the PMSI (Programme de Médicalisation des Systèmes d'Information), we will use all hospital stays from 2011 to 2020 for alcohol detoxification in France, both in public and private settings.

For each hospital stay will be collected the length, the antecedents of hospital alcohol detoxification, clinical and psychiatric comorbidities, withdrawals complication, alcohol use complication, further examinations.

We will describe the stays using median and quartiles for continuous variables and number and percentage for dichotomous variables. For secondary objectives, we will use a multivariate linear regression model if the length of stay is normal, an ordinal regression model otherwise. The characteristics of the stays will be compared regarding the type of facility using univariate comparative tests: Chi² or Fisher for dichotomous variables and Student or Mann-Whitney for continuous variables.

Studietype

Observationeel

Inschrijving (Werkelijk)

50000

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Montpellier, Frankrijk, 34295
        • Uhmontpellier

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

French patients hospitalized for alcohol detoxification from 2011 to 2020

Beschrijving

Inclusion criteria:

Inclusion criteria:

  • French patients of at least 18 years old
  • Inpatients of a public or private care facility for alcohol detoxification
  • From 01/01/2011 to 12/31/2020
  • In a medical or psychiatric hospital

Exclusion criteria:

- age < 18 years

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Cohorten en interventies

Groep / Cohort
Interventie / Behandeling
Inpatients for alcohol detoxifications
French patients who were hospitalized for alcohol detoxification from 2011 to 2020
Stay for alcohol detoxification : routine care.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
description of age
Tijdsspanne: day 1 (At hospital inclusion)
Age at admission (in years), calculated by the difference of the year of admission and the year of birth through the PMSI.
day 1 (At hospital inclusion)
description of sex
Tijdsspanne: day 1 (At hospital inclusion)
Sex collected through the PMSI.
day 1 (At hospital inclusion)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
description of geographic code
Tijdsspanne: day 1 (At hospital inclusion)
Sex collected through the PMSI.
day 1 (At hospital inclusion)
description of CMU-C
Tijdsspanne: day 1 (At hospital inclusion)
CMU-C (universal complementary health insurance, collected through the PMSI.
day 1 (At hospital inclusion)
Length of stay
Tijdsspanne: During the stay (day 1 - day 15)
Length of stay (in days), calculated by the difference between the discharge date and the entry date, collected through the PMSI.
During the stay (day 1 - day 15)
Care establishment
Tijdsspanne: During the stay (day 1 - day 15)
Name and type of the care establishment, collected through the PMSI.
During the stay (day 1 - day 15)
Number of previous hospital detoxification stays in the studied period
Tijdsspanne: During the stay (day 1 - day 15)
Number of previous hospital detoxification stays in the studied period, collected through the PMSI.
During the stay (day 1 - day 15)
Psychiatric comorbidities
Tijdsspanne: During the stay (day 1 - day 15)
Psychiatric comorbidities (Major depression episode, anxiety, psychotic trouble, personality diseases), collected through the PMSI.
During the stay (day 1 - day 15)
Withdrawal complication
Tijdsspanne: During the stay (day 1 - day 15)
Withdrawal complications (delirium tremens, comitial seizures), collected through the PMSI.
During the stay (day 1 - day 15)
Further examination
Tijdsspanne: During the stay (day 1 - day 15)
Further examination (biology, imagery, etc…), collected through the PMSI.
During the stay (day 1 - day 15)
Re-hospitalization for same reason
Tijdsspanne: day 1
For each patient, and each stay, we will evaluate if the patient had an ulterior re-hospitalization for alcohol withdrawal. Collected through the PMSI.
day 1

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Lionel MOULIS, University Hospital, Montpellier

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 mei 2021

Primaire voltooiing (Werkelijk)

30 augustus 2021

Studie voltooiing (Werkelijk)

30 augustus 2021

Studieregistratiedata

Eerst ingediend

6 juli 2021

Eerst ingediend dat voldeed aan de QC-criteria

21 juli 2021

Eerst geplaatst (Werkelijk)

22 juli 2021

Updates van studierecords

Laatste update geplaatst (Werkelijk)

19 oktober 2021

Laatste update ingediend die voldeed aan QC-criteria

18 oktober 2021

Laatst geverifieerd

1 oktober 2021

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Beschrijving IPD-plan

NC

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren